# LEQVIO

NDC: 0078-1000
Generic name: inclisiran
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20211222

FDA application: NDA214012

## Active ingredients

- INCLISIRAN SODIUM: 284 mg/1.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1000"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1000
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fc0afca-4513-4c35-b594-6544aee29a44